Navigation Links
Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk
Date:8/7/2009

Women with BRCA gene mutations often choose preventive measures, study finds

FRIDAY, Aug. 7 (HealthDay News) -- Many women with a high risk of breast or ovarian cancer have surgery to remove their breasts or ovaries in order to reduce the likelihood of developing cancer, English researchers report.

Their study included 211 women, aged 35 to 45, with BRCA1 or BRCA2 gene mutations, which are known to increase the risk of breast and ovarian cancer. The women found out about their increased risk after undergoing genetic testing.

"Women have their breasts or ovaries removed based on their risk. It does not always happen immediately after counseling or a genetic test result and can take more than seven years for patients to decide to go forward with surgery," lead researcher Dr. D. Gareth Evans, a consultant in clinical genetics at the Genesis Prevention Center, University Hospital of South Manchester NHS Trust, and professor at the University of Manchester, said in a news release.

Evans and colleagues found that women who had a biopsy after undergoing risk evaluation were twice as likely to undergo mastectomy. Even when the tissue was benign, most of the women were likely to opt for risk reduction surgery.

Forty percent of women with BRCA1 and BRCA2 gene mutations had both breasts removed and 45 percent had both ovaries removed.

When looked at separately, 52 percent of BRCA1 gene mutation carriers had both ovaries removed, compared with 28 percent of BRCA2 gene mutation carriers, the researchers found.

"We found that older women were much less likely to have a mastectomy but were more likely to have their ovaries removed," Evans said.

Most women decided to have breast or ovary removal surgery within two years after their genetic test, but some took seven years to make the decision, according to the report published in the Aug. 1 issue of Cancer Epidemiology, Biomarkers & P
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. One Surgery Often Enough for Peritonitis
2. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
3. Surgery for severe obesity saves lives
4. Some Epilepsy Patients Are Good Candidates for Surgery
5. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
6. Hypnosis Eases Pain of Breast Cancer Surgery
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. Minimally Invasive Heart Surgery Research Wins N.I.H. Award
9. Cosmetic Surgery & Exotic Brazil
10. Small Incisions Make Heart Valve Surgery Safer
11. Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk
Many Opt for Surgery to Lower Breast, Ovarian Cancer Risk
(Date:11/23/2009)... After suffering from women,s hair loss...rowing back and she,s sharing her progress and the... women through the release of her video diaries wh... and during her treatment. , ...r loss sufferer Zsanett Siklosi has released the ...
(Date:11/23/2009)...O,Pa.,Nov.23/PRNewswire-FirstCall/--InfoLogix,Inc....risemobilitysolutionsforthehealthcareandcommercial...identofManagedServicesatSiemensHealthServices,hasj...Services. ,, (Logo: http://www.newscom.com/cgi-...entofStrategicHealthcareServicesforInfoLogix,Mr.Wa...
(Date:11/23/2009)...rs of cancer patients and survivors treated with c...t often become chronic conditions, hindering patie...ists at the University of Rochester Medical Center...xperienced sleep troubles at nearly three times th...more prevalent in younger patients and those with ...
(Date:11/23/2009)...w their odds drop by 63 percent with moderate-to-h...23 (HealthDay News) -- Moderate-to-high intensity ...elp reduce stroke risk in older men but not in wom...most 3,300 men and women, average age 69, in Manha...g that time, there were 238 strokes among the part...
(Date:11/23/2009)...p weaknesses of drug approval process in United St...3 (HealthDay News) -- Problems with the popular ar...eart attack, stroke and death, were known for year...market in 2004, a new report says. , Contrary ...ngerous side effects were evident in 2000, a year ...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2Health News: Vioxx Problems Known Years Before Recall 2Health News: Vioxx Problems Known Years Before Recall 3Health News: Vioxx Problems Known Years Before Recall 4
...with cervical spinal injury may have more damage t...hed in the Annals of Emergency Medicine, say that ...n patients over and above the normal X-rays.// ...re than a third of patients who were thought to ha...
..., researchers from University of South Florida had...Gerontology: Psychological Sciences that the more ... may have a role to play in reducing the risk of d... and dementia in general. Researchers had discover...
Dengue, the mosquito-transmitted lethal disease that has claimed 15 lives and afflicted 1,000 people in West Bengal so far, has been declared an epidemic by the state government.// State Health Di
...tment of had discovered a new way to test the stem...// The researchers had used a non-invasive i... trace stem cells’ destinations after being inject... myocardial infarctions in seven dogs, six of whic...
...l significantly reduces the spread of gastrointest...ilies studied, half of the families, which used th... in the spread of illness related to the gastroint...zer and educational materials on hand hygiene. The...
...ve that governs the flow of blood into a large blo...o various organs of the body. // It prevents the b...est of the body. The effective functioning of.... The defect can be present right form birth or it...
Other Medicine News:Health News:Alcohol based sanitizer found to reduce illness in families 2Health News:Percutaneous aortic valve replacement- a revolution in Cardiac Surgery 2
(Date:11/23/2009)...,Nov.23/PRNewswire-USNewswire/--JubilantOrganosys,...nResearchInstitutetodayannouncedajointventurethatw...ablingtechnologiesintheareasofOncology,MetabolicDi...bitragedandleveragedpartnershipthatwillacceleratet...wide.AMemorandumofUnderstandingwassignedtodayinWas...
(Date:11/23/2009)...-BioTrendsResearchGroup,Inc.releasedWave2ofits La...lti-phasesyndicatedmarketresearchprojecttrackingth...efirstsixmonthsofproductavailability.Eachwaveofthe...ephrologistsandqualitativeinformationfromasubsetof...touse,reasonstouse,typicalpatienttypes,productperc...
(Date:11/23/2009)...rstCall/--CordBloodAmerica,Inc.(OTCBulletinBoard:C...any( http://www.cordblood-america.com )focusedonbr...linsurancepolicy,tofamiliesnationwideandinternatio...withCEOandco-founderMatthewSchisslerisnowavailable...e/2875811 . ,, Intheinterview,Mr.Schisslerupdat...
Breaking Medicine Technology:Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 1Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 2Canadian Cancer Society Selects Branded Merchandise Solutions From Boundless Network 61066 3Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 1Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 16 2009 14777 2PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 1PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 2PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 3PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 4PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 5PLC Systems Reports Third Quarter 2009 Results 3B Announces Distribution Agreement for RenalGuard 28R 29 in Brazil 6136 6
...to Timeline for Second Pivotal Phase 3 Trial CL-05... Advanced Life,Sciences Holdings, Inc. , today ann...ata from Trial CL-06, the first of two,pivotal Pha... and,effectiveness of cethromycin, a novel once-a-...uired pneumonia (CAP). The Company,also provided a...
..., July 2, 2007-Women with at least three sites of,...times more likely,than average women to develop br...c Cancer Center led study of women with atypical,h... 1 issue of the,Journal of Clinical Oncology., Sev...erplasia,(also called atypia) in breast tissue is ...
Other Medicine Technology:Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 2Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast,Cancer Risk Prediction in Women with Atypia 3
Carter Sphere Introducer and Holder
Symblepharon Ring - Medium
Oval Sponge Implants - 3.0 x 5.0 x 100 mm
Grooved Segmental Buckle - 2.3 x 6.4 x 80 mm
Medicine Products: